Short Interest in Procaps Group S.A. (NASDAQ:PROC) Decreases By 21.7%

Procaps Group S.A. (NASDAQ:PROC) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 163,300 shares, a decrease of 21.7% from the November 30th total of 208,500 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 96,000 shares, the days-to-cover ratio is presently 1.7 days.

Procaps Group Stock Performance

Shares of NASDAQ PROC traded down $0.07 during trading on Monday, reaching $2.28. The stock had a trading volume of 24,749 shares, compared to its average volume of 35,466. The stock has a market cap of $257.23 million, a PE ratio of 4.38 and a beta of 0.10. Procaps Group has a one year low of $0.50 and a one year high of $4.95. The firm’s 50 day moving average price is $1.82 and its two-hundred day moving average price is $2.06.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.